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Abstract 24 
Replicons from bifidobacteria species are required for the construction of general- 25 
and special-purpose vectors that would allow the undertaking of molecular studies of 26 
these bacteria. In this work, pSP02, a cryptic plasmid from Bifidobacterium longum 27 
M62, was cloned, sequenced and characterized. pSP02 was found to consist of 4896 bp 28 
with four ORFs coding for proteins over 50 amino acids long. Among the deduced 29 
protein sequences only a replicase (RepA) and a mobilization-like protein (MobA) 30 
showed known functional domains. Similar to previously described bifidobacterial 31 
plasmids, the organization of the putative ori region of pSP02 resembles that of the 32 
theta-replicating plasmids of Gram-positives. In spite of this, hybridization experiments 33 
detected single stranded (ss)-DNA as an intermediate product in the pSP02 replication, 34 
demonstrating it follows the rolling-circle (RC) replication mode. The ori region of 35 
pSP02 was used to construct a series of first generation cloning vectors able to replicate 36 
in many bifidobacterial species. Real time quantitative PCR established the copy 37 
number of pSP02 and its derived vectors to be around 12 copies per chromosome 38 
equivalent. pSP02-derivatives showed full segregational and structural stability even in 39 
the absence of antibiotic selection. 40 
 41 
 42 
Introduction 43 
Bifidobacterium species are among the dominant microbial populations of the 44 
gastrointestinal tract (GIT) of humans and other mammals, where they are considered to 45 
be responsible for a vast array of effects beneficial to health, including the production of 46 
short chain fatty acids, the exclusion of intestinal pathogens, and the modulation of 47 
immune function (Russell et al., 2011). These beneficial activities have led to the 48 
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extensive use of selected bifidobacterial strains as probiotics. However, the basic 49 
mechanisms by which bifidobacteria contribute to well-being remain poorly understood. 50 
This knowledge is extremely important for the long-term exploitation of bifidobacterial 51 
probiotics as promoters of health (Russell et al., 2011; Siciliano and Mazzeo, 2012). 52 
The molecular study of bifidobacterial properties has traditionally been hampered by 53 
a lack of genetic tools (Ventura et al., 2004). Bifidobacteria have recently been 54 
envisioned as promising systems for the delivery of therapeutic agents such as antigens 55 
(for live vaccine development) and tumor-suppressing substances (Fujimori, 2006; Xu 56 
et al., 2007), but for this, stable and robust expression vectors are also needed. The lack 57 
of molecular tools further impedes the full exploitation of the genetic data provided by 58 
the recent genome sequencing of many bifidobacterial strains 59 
(http://www.ncbi.nlm.nih.gov/sutils/genom_table.cgi). Since bacteriophages infecting 60 
Bifidobacterium species have never been characterized, and only a few prophage-like 61 
element have been identified in the bifidobacterial genomes (Ventura et al., 2005), 62 
plasmids would seem to be the only feasible type of replicon that can be used to 63 
construct these needed vectors. 64 
To date over 40 plasmid sequences have been reported to the GenBank database 65 
(http://www.ncbi.nlm.nih.gov/nuccore), and a few plasmid replicons have been studied 66 
in detail (O’Riordan and Fitzgerald, 1999; Park et al., 1999; Corneau et al, 2004; Lee 67 
and O’Sullivan, 2006; Park et al., 2008). Some of these have already been used to 68 
construct general cloning and expression vectors (Matsumara et al., 1997; Yazawa et al., 69 
2001; Klijn et al., 2006; Rhim et al., 2006; Takata et al., 2006; Cronin et al., 2007; 70 
Álvarez-Martín et al., 2008), and some special-purpose vectors, such as 71 
bioluminescence reporter systems (Cronin et al., 2008; Guglielmetti et al., 2008). 72 
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However, more plasmids are still needed to develop compatible vector systems and 73 
construct food grade vectors and gene integration, disruption and replacement cassettes. 74 
This work reports the molecular analysis of pSP02, a cryptic plasmid from 75 
Bifidobacterium longum M62. This replicon was used to construct first generation 76 
cloning vectors able to replicate stably in different bifidobacterial species and strains, 77 
including some used as commercial probiotics. 78 
 79 
 80 
Material and Methods 81 
 82 
Bacterial strains, cloning vectors and growth conditions 83 
Table 1 shows the bacterial strains and vectors used in this study. Bifidobacteria 84 
strains were grown in anaerobiosis at 37ºC in MRS broth (Merck, Darmstad, Germany) 85 
or RCM broth (Merck) supplemented with 0.25% (w/v) L-cysteine (Sigma-Aldrich, St. 86 
Louis, MO, USA). Escherichia coli was grown with shaking at 37ºC in Luria Bertani 87 
(LB) broth (Sambrook and Russell, 2001). When required, antibiotics (all from Sigma-88 
Aldrich) were added at the following concentrations: ampicillin 100 µg ml
-1
 and 89 
tetracycline 5 µg ml
-1
 for E. coli and erythromycin 5 µg ml
-1
 and tetracycline 5 µg ml
-1
 90 
for bifidobacteria. 91 
 92 
Isolation of plasmid DNA 93 
Plasmid DNA from bifidobacteria was isolated using the method of O’Sullivan and 94 
Klaenhamer (1993) with the modification that pellets were suspended in TSE buffer 95 
(sucrose 25%, 50 mM Tris-HCl, 10 mM EDTA, pH 8.0) and incubated with lysozyme 96 
(30 mg/ml) at 37ºC for 30 min. Plasmid DNA from E. coli was isolated using the 97 
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commercial QIAprep® Spin Miniprep kit (Qiagen GmbH, Hilden, Germany), following 98 
the manufacturer’s recommendations. Plasmids were analyzed by electrophoresis in 99 
TAE (40 mM Tris-HCl, 40 mM acetic acid, and 1 mM EDTA, pH 8.0), visualized under 100 
UV light and photographed. 101 
 102 
Molecular DNA techniques 103 
The general procedures followed for DNA manipulation were essentially those 104 
described by Sambrook and Russell (2001). Restriction endonucleases (Takara, Otsu, 105 
Shiga, Japan), Taq DNA polymerase (Ampliqon A/S, SkovlundeDenmark), the Klenow 106 
fragment of E. coli polymerase I and nuclease S1 (Roche Applied Sciences, Basel, 107 
Switzerland), and T4 DNA ligase (Invitrogen, Carlsbad, CA; USA) were used according 108 
to the suppliers’ instructions. 109 
Cloning vectors and constructs were introduced into E. coli by electrotransformation 110 
(electroporation) using a Gene-Pulser Apparatus (Bio-Rad Laboratories, Richmond, 111 
CA, USA) according to Sambrook and Russell (2001). Electroporation of 112 
Bifidobacterium cells was performed under the following conditions: 25 µF, 200 Ω and 113 
10 kV (Álvarez-Martín et al., 2007). Transformants were recovered on selective RCM 114 
agar plates incubated for 2-3 days at 37ºC under anaerobic conditions. 115 
 116 
Sequencing and DNA sequence analysis 117 
The complete pSP02 sequence was obtained by sequencing cloned plasmid BamHI 118 
fragments into pUC18. In addition, the sequence of some segments was further verified 119 
by PCR amplification and sequencing of the amplicons. DNA and deduced protein 120 
sequences were examined for homology against non-redundant DNA and protein 121 
databases using the on-line BLAST program (http://blast.ncbi.nlm.nih.gov/Blast.cgi). 122 
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 123 
DNA hybridization 124 
Plasmid DNA was transferred to Hybond-N nylon membranes (GE Health Care Bio-125 
Sciences, Little Chalfont, UK) after electrophoresis and hybridized, using as a probe a 126 
digoxigenin-labeled internal segment of the repA gene obtained by PCR, under high-127 
stringency standard conditions (hybridization at 68ºC and two final washing steps in 0.5 128 
x SSC, 0.1% SDS at 68ºC for 15 min) (Sambrook and Russell, 2001). 129 
For the detection of ssDNA, whole-cell lysates from B. pseudocatenulatum M115 130 
harboring pSP1 were obtained and purified as described by Leenhouts et al. (1991). 131 
Unmodified DNA and DNA treated with nuclease S1 were then electrophoresed and 132 
transferred to a hybridization membrane under non-denaturing conditions. ssDNA was 133 
revealed by hybridization using the same repA-derived probe and labeling conditions as 134 
above. 135 
 136 
Determination of the relative plasmid copy number 137 
The relative copy number of pSP02 and its derived vectors was assessed by 138 
quantitative real-time PCR (qPCR) in a Fast Real-Time PCR system (Applied 139 
Biosystems, Foster City, CA, USA) using Power SYBER® Green PCR Master Mix 140 
(Applied Biosystems), and employing the PCR conditions reported by Álvarez-Martín 141 
et al. (2008). Amplification of a segment of 139 bp was performed using two primers -142 
CopyF and CopyR (Table 1)- based on the pSP02 repA sequence. A 148 bp segment of 143 
the single-copy Tu elongation factor gene of B. longum NCC2705 (tuf; GeneID: 144 
1022637) was used as a reference. The relative copy number was calculated from 145 
triplicate experiments using the formula Nrelative= (1+E)
-ΔCT
 (Lee et al., 2006), where E is 146 
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the amplification efficiency of the target and reference genes, and ΔCT the difference 147 
between the threshold cycle number (CT) of the tuf reaction and that of repA. 148 
 149 
Segregation and structural stability of vectors 150 
The stability of the constructs was assayed in B. pseudocatenulatum M115 by 151 
growing the cells in non-selective RCM-cysteine medium for approximately 100 152 
generations and plating daily onto antibiotic-free agar plates. Plasmid segregation was 153 
monitored by transference of the colonies to plates with and without antibiotics. Finally, 154 
structural stability was monitored in representative resistant and susceptible colonies by 155 
plasmid isolation and restriction analysis. 156 
 157 
Nucleotide sequence accession number 158 
The nucleotide and deduced amino acid sequences of pSP02 are available under 159 
GenBank accession no. GU256055. 160 
 161 
 162 
Results and Discussion 163 
 164 
Cloning and sequencing of pSP02 165 
The plasmid complement of B. longum M62 has been shown to be composed of three 166 
plasmids of lengths around 3.5 (pSP01), 5.0 (pSP02) and 14.0 (pSP03) kbp (Álvarez-167 
Martín et al., 2007). Restriction analysis of the whole plasmid complement of strain 168 
M62 showed pSP02 to be digested by BamHI into two fragments of approximately 2.35 169 
and 2.65 kbp; neither pSP01 nor pSP03 were cut with this enzyme. The digestion 170 
fragments were ligated into BamHI-digested pUC18, and the ligation mixture 171 
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electroporated into E. coli DH11S. Plasmid DNA from each of the clones was isolated, 172 
purified and sequenced. To check the sequence around the BamHI positions, primers 173 
were designed to amplify segments flanking the BamHI sites (Table 1). Sequencing of 174 
the amplicons confirmed that the whole molecule of pSP02 was composed of only these 175 
two BamHI fragments, and to be 4896 bp long. The single KpnI restriction enzyme site 176 
was used as a starting point for numbering nucleotides in a clockwise direction with 177 
respect to the ORF encoding the putative replicase RepA (Fig. 1). The GC content of 178 
the plasmid molecule was shown to be 62%, slightly higher than that recorded for the B. 179 
longum chromosome (60%) (Schell et al., 2002). It also showed a nucleotide sequence 180 
almost identical to that of other bifidobacterial plasmids, such as p6043A from B. 181 
longum DPC6043 (DQ458910), pB80 from Bifidobacterium bifidum B80 (DQ305402; 182 
Shokoporov et al., 2008), or pBIFA24 from Bifidobacterium spp. A24 (DQ286581). 183 
Less -but still extensive- homology was shown with the sequence of plasmids pKJ50 184 
(BLU76614; Park et al., 1999), p157F-NC2 (AP010891) and pNAL8M (AM183144; 185 
Guglielmetti et al., 2007), and others. Furthermore, hybridization experiments using as a 186 
probe the whole repA gene amplified with primers RepAF and RepAR (Table 1) 187 
showed a replicon closely related to pSP02 to be present in certain plasmid-containing 188 
strains of our collection (data not shwon). Thus, a plasmid identical or very similar to 189 
pSP02 seems to be well spread among B. longum strains, and is also present in other 190 
bifidobacterial species (Shkoporov et al., 2008). As these plasmids are all cryptic, the 191 
biological significance of the presence of pSP02-type replicons is at present unknown. It 192 
may represent a very successful replicon in bifidobacteria, as is the case of WO02-type 193 
plasmids in Lactococcus lactis (Seegers et al., 1994). 194 
 195 
Sequence analysis of pSP02 196 
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Four ORFs coding for proteins over 50 amino acids long were predicted into the 197 
pSP02 molecule (Fig. 1). Among the deduced proteins only a replicase (RepA) and a 198 
mobilization-like protein (MobA) showed any known functional domain. RepA was 199 
shown to consist of 303 amino acids long harboring a conserved replicase domain of the 200 
Rep_3 protein superfamily (pfam01051). BLAST analysis showed RepA to differ from 201 
the equivalent sequence of plasmid pB80 of B. bifidum B80 (Shkoporov et al., 2008) by 202 
a single amino acid, and by two amino acids with respect to pNAL8M (Guglielmetti et 203 
al., 2007). All these plasmids can be included in the phylogenetic group Ia of the 204 
bifidobacterial plasmids (Guglielmetti et al., 2007). The deduced MobA protein of 205 
pSP02 is thought to be composed of 370 amino acids. The protein contained a 206 
conserved domain of transfer relaxases of the MobA_MobL superfamily (pfam03389). 207 
The deduced amino acid sequence of two additional ORFs, orf1 and orf2, showed no 208 
putative conserved domains and share no homology to proteins in the databases. 209 
A large number of direct (DR) and inverted (IR) repeats were detected in the pSP02 210 
sequence. The approximate position of all these are indicated in Fig. 1. Secondary 211 
structures of DRs and IRs were particularly abundant between orf2 and repA genes. 212 
These secondary structures conform what it is supposed to be the origin of replication 213 
(ori) of pSP02, a region which is detailed in Fig. 2. In fact, the organization of this 214 
region resembles that found in the ori region of plasmids of Gram-positive bacteria in 215 
which the theta mode of replication has been experimentally demonstrated (Kiewiet et 216 
al., 1993; del Solar et al., 1998). Two AT-rich stretches of 30 and 27 nt were identified 217 
in this region, which are flanked by a typical DR of 22 nt (DR-6), repeated three times 218 
and featuring an iteron structure similar to that in pKJ50 (Park et al., 1997). The first 219 
and third repeats are identical and embrace an imperfect repeat in the middle (DR-6*) 220 
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(Fig. 2). Also noteworthy in the pSP02 sequence is the presence of a long IR of 38 nt, 221 
the two copies of which are separated by more than 900 bps (IR-2 in Fig. 1). 222 
No canonical oriT-like sequence was identified in front of mobA. However, a short 223 
inverted repeat of eight nt (5’-ATGTTACC-GGT-GGTAACAT-3’) separated by six bp 224 
from a 12 nt sequence (5′-TAAGTGCGCCCT-3′) resembling that present in some 225 
mobilizable plasmids from Gram-positive bacteria (Lee and O’Sullivan, 2006), was 226 
found through positions 3086 to 3050, 228 bp upstream of the start codon of mobA. 227 
 228 
Construction of pSP02-derived vectors 229 
Fig. 3 shows the general outline for the construction of the pSP02-derivatives. A 230 
clone in pUC18 carrying the BamHI fragment encoding repA was digested with BamHI 231 
and ligated into BamHI-digested pUC19E, a pUC-derived vector unable to replicate in 232 
bifidobacteria but harboring the erythromycin resistance gene of pE194 from 233 
Staphylococcus aureus. The ligation mixture was electroporated into electrocompetent 234 
Bifidobacterium pseudocatenulatum M115 cells. Transformants carrying the pSP02 235 
fragment in the two opposite orientations were found, showing that orientation was not 236 
essential for replication. It was also shown that neither mobA nor orf1 nor the IRs 237 
present in the other half of the molecule was necessary for replication. 238 
One construct carrying the replicase in the same relative orientation to that of the 239 
betalactamase gene in pUC19E, named pSP1 (Fig. 3), was selected and further 240 
modified. As shown in the figure, the erythromycin resistance gene in pSP1 was 241 
replaced by a bifidobacterial tet(W) gene encoding resistance to tetracycline (Álvarez-242 
Martín et al., 2008), giving raise to pSP2 (Fig. 3). This construct was first obtained in E. 243 
coli and then transformed into B. pseudocatenulatum. 244 
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Finally, pSP1 was double digested with EcoRI and HindIII, treated with the Klenow 245 
fragment of E. coli DNA polymerase I, re-ligated and transformed into the M115 strain. 246 
Transformants lacking DNA from the pUC vector were recovered, thus demonstrating 247 
that the replication of this construct, called pSP3 (Fig. 3), was driven by sequences and 248 
elements from the pSP02 segment. 249 
 250 
Host range, copy number and stability of pSP02 derivatives 251 
A series of bifidobacterial strains belonging to different species, including 252 
recognized probiotic strains such as Bifidobacterium animalis subsp. lactis Bb12 and 253 
Bifidobacterium breve UCC 2003 (Table 2), were made competent and transformed 254 
with one g of DNA from all pSP02-derived constructs (pSP1, pSP2, and pSP3). 255 
Though the transformation frequency varied widely among the different constructs and 256 
strains, transformants were recovered in all cases, except for pSP3, for which, as 257 
expected, transformants in E. coli were not obtained. As a general trend, pSP1 and pSP3 258 
showed similar transformation frequencies in the different hosts, while fewer 259 
transformants were usually obtained for pSP2. Transformants were obtained at low 260 
frequency for pSP1 and pSP3 in a single strain of Corynebacterium glutamicum, which 261 
belongs to the same phylum as bifidobacteria (Actinobacteria). However, no 262 
transformants with pSP02-derivatives were recovered in several lactic acid bacterial 263 
strains (Table 2), suggesting the replicon is not functional in this bacterial group. 264 
The relative copy number per chromosome equivalent of pSP02 was analyzed in its 265 
original host B. longum M62 by qPCR; those of the constructs were analyzed after 266 
transformation into the plasmid-free strain B. longum L25. The standard amplification 267 
curves both repA and tuf genes were linear over the tested range in both strains (average 268 
R2 >0.993). Assuming maximum and identical amplification efficiencies for the target 269 
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(repA) and reference (tuf) genes, the relative copy numbers per chromosome equivalent 270 
of pSP02 was estimated to be around 12 copies in both strains (11.83±0.64 in B. longum 271 
L25 and 12.39±0.92 in B. longum M62). A similar copy number was also established 272 
under the same experimental conditions for all pSP02-derivatives in B. longum L25. 273 
Copy number of pSP02 showed to be intermediate to that of pBC1 (30 copies per cell) 274 
(Álvarez-Martín et al., 2007) and pCIBAO89 (4 copies per cell) (Cronin et al., 2007). 275 
pSP1, pSP2, and pSP3 were checked for stability under non-selective conditions in 276 
B. pseudocatenulatum M115. After 100 generations more than 80% of the colonies 277 
retained each of the constructs. Plasmid analysis by digestion with restriction enzymes 278 
showed that antibiotic resistant colonies contained the constructs without appreciable 279 
structural changes. 280 
pSP1 was also electroporated into strain M115 containing pAM4, a cloning vector 281 
based on pBC1 from B. catenulatum L48 (Álvarez-Martín et al., 2008). The two 282 
plasmids remained compatible and were stably maintained at similar frequencies to 283 
those shown by each of the construct in this host. 284 
 285 
Mode of replication of pSP02 286 
As B. longum M62 carries three plasmids, to investigate the mode of replication of 287 
pSP02, total DNA was isolated from an overnight culture of B. longum L25 harboring 288 
vector pSP1. Purified untreated DNA and DNA treated with nuclease S1 were 289 
transferred to a membrane under non-denaturing conditions and hybridized with the 290 
above referred recA-derived probe. As can be seen in Fig. 4, pretreatment of the DNA 291 
with nuclease S1, resulted in the loss of a hybridization band which is thought to 292 
correspond to ssDNA. The detection of ssDNA as an intermediate in the replication of a 293 
plasmid is currently used as a proof of using the RC type of replication (del Solar et al., 294 
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1998; Khan, 1997). The apparent discrepancy between the physical organization of the 295 
ori region of pSP02 (similar to theta-replicating plasmids) and the replication 296 
proceeding by the RC mode has previously been noted for other B. longum plasmids 297 
such as pKJ50 (Park et al., 1999) and pDOJH10L-RepB (Lee and O’Sullivan, 2006). 298 
In conclusion, a cryptic plasmid from B. longum was analyzed and used for the 299 
construction of cloning vectors that replicate in different bifidobacterial species. 300 
Although presenting an iteron-like structure and other elements typical of theta-301 
replicating plasmids (AT-rich regions separated by GC-rich stretches), pSP02 was 302 
shown to replicate through ssDNA intermediates, consistent with an RC mode. pSP02-303 
derived constructs showed convenient stability and copy number. These new plasmid 304 
vectors could complement the genetic tools already available for performing molecular 305 
studies on bifidobacteria and their genetic manipulation. 306 
 307 
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Table 1.- Bacterial strains, plasmids and oligonucleotide primers utilized in this work. 518 
 519 
Item Genotype, phenotype or sequence Source or reference 
   
Strains   
Escherichia coli DH11S 
mcrA, Δ(mrr-hsdRMS-mcrBC), Δ(lac-proAB), Δ(rec1398), deoR, 
rpsL, srl-thi-/F'proAB+ lacIqZΔM15 
Invitrogen 
Bifidobacterium longum M62 
Human intestinal isolate harbouring three cryptic plasmids, 
including pSP02 
Álvarez-Martín et al. (2007) 
B. longum C63 Human intestinal isolate harbouring two cryptic plasmids Álvarez-Martín et al. (2007) 
B. longum C72 Human intestinal isolate harbouring three cryptic plasmids Álvarez-Martín et al. (2007) 
B. longum L25 Human isolate, plasmid free IPLA Laboratory Collection 
Bifidobacterium adolescentis LMG 10502 Human intestinal isolate, plasmid-free BCCM/LMG
1
 
Bifidobacterium animalis LMG 10508 Human intestinal isolate, plasmid-free BCCM/LMG 
Bifidobacterium animalis subsp. lactis Bb12 Isolated from a fermented milk starter Chr. Hansen, Denmark 
Bifidobacterium breve LMG 13208 Human intestinal isolate, plasmid-free BCCM/LMG 
Bifidobacterium catenulatum L48 Human intestinal strain containing pBC1 Álvarez-Martín et al. (2007) 
Bifidobacterium pseudocatenulatum M115 Human intestinal isolate, plasmid-free IPLA Laboratory Collection 
Bifidobacterium pseudolongum LMG 11571 Human intestinal isolate, plasmid-free BCCM/LMG 
Bifidobacterium thermophilus LMG 11571 Human intestinal isolate, plasmid-free BCCM/LMG 
Corynebacterium glutamicum LMG 19741 Plasmid-free BCCM/LMG 
Enterococcus faecalis ATCC 47077 Plasmid-free ATCC
2
 
Lactobacillus casei ATCC 393 Plasmid-free ATCC 
Lactococcus lactis subsp. cremoris MG 1363 NCDO 712 derivative, plasmid-free Laboratory collection 
   
Plasmids   
pUC18 Cloning vector, Ap
r
, 2.686 Kbp Yanisch-Perron et al. (1985) 
pUC19E pUC-based cloning vector, Ap
r
 Em
r
, 3665 bp Laboratory collection 
pAM4 E. coli-Bifidobacterium shuttle vector; Ap
r
 Em
r
 Tet
r
 [tet(W)] Álvarez-Martín et al. (2008) 
pSP1 E. coli-Bifidobacterium shuttle vector; Ap
r
 Em
r
, 6224 bp This work 
pSP2 E. coli-Bifidobacterium shuttle vector; Ap
r
 Tet
r
, 7716 bp This work 
pSP3 Bifidobacterium vector, Em
r
, 3594 This work 
   
Oligonucleotides (5’-3’)  
Bam1F GATGATCGGATGGAGCCTG (315 bp apart from Bam1R) This work 
Bam1R CGATTGGCGTCGTCGATGG This work 
Bam2F CACGGCTCACGTTCGACAC (275 bp apart from Bam2R) This work 
Bam2R GTCCATGCACCGCTCTATGC This work 
RepAF ATGTCCGATGAGATCGTGAAG This work 
RepAR CGCAGCACTCGGCCAGTC This work 
CopyF CACGTTCGAAGAATTGAAG (101 bp apart from CopyR) This work 
CopyR GATGATGTCGTGCTCTTCG This work 
TufF GGAGTACGACTTCAACCAG (110 bp apart from TufR) This work 
TufR CATGTTCTTCACGAAGTCG This work 
   
Ap
r
, Em
r
, and Tet
r
, resistance to ampicillin, erythromycin, and tetracycline, respectively. 520 
1
BCCM/LMG, Belgium Coordinated Collection of Microorganisms/Laboratory for Microbiology, University of Gent, Belgium 521 
2
ATCC, American Type Culture Collection. 522 
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Table 2.- Host range and transformation frequency of pSP02-derived vectors. 
 
Species and strain 
Transformants
1
 per g of DNA
2
 of the vector 
pSP1 pSP2 pSP3 
    
B. adolescentis LMG 10502 2.3x10
2
 3.6x10
1 1.4x102 
B. animalis subsp. animalis LMG 10508 7.4x10
1 5.0x100 5.8x101 
B. animalis subps. lactis Bb12 1.8x10
1 6.0x100 3.0x101 
B. breve UCC 2003 3.5x10
3 8.2x102 4.2x103 
B. longum L25 6.5x10
1 3.0x100 2.3x102 
B. pseudocatenulatum M115 1.2x10
4 6.3x103 4.6x105 
B. pseudolongum LMG 11571 4.2x10
1 4.1x101 3.6x101 
B. thermophilus LMG 11571 1.9x10
1 2.2x101 8.0x100 
    
Corynebacterium glutamicum LMG 19741 1.6x10
1 0 5.0x100 
    
Enterococcus faecalis ATCC 47077 0 0 0 
Lactobacillus casei ATCC 393 0 0 0 
Lactococcus lactis subsp. cremoris MG 1363 0 0 0 
    
Escherichia coli DH11S 6.2x10
6 6.8x106 0 
    
1
Results are the mean of two independent transformations. 
2
The DNA of all constructs was isolated from B. pseudocatenulatum M115. 
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KpnI (1) 
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                                       DR-3                         DR-3 
CATCCGGCTG GGCGGCATCC TCTCCAACGA GGGCGTGCTT GGCTACGACG AGGGCGTCTG 3720 
                                                                  DR-4 
        DR-4                                                 IR-8  
GAACGACGAG GGCAACCGGC AAAGGCTGCT GGACATGCTC AAGGCCCATG CCGCCGAACT 3780 
          IR-8 
GCGCGCATGG GCCTCTGACG CGGGCGTGAG GCTCCCCAGC GCTGAGTCGG CGGGTGAGCT 3840 
GCGGGAACGG TTCGTGACCT GCCCCAAGAG CCTCAGATAC AGGAGCAGCC GGGCTATGGC 3900 
TACCAGCCCG GATTCCAACA GCCACAGCAA TGGCAGCAGC AGCCTTGGAA CTGAGTCGGT 3960 
                                                     A+T rich 1 
TTCTTCTCTT CATCGGGGCG GAGCCCCTTT TTATAGAATC TTTTGTACTC TTTTAGACTC 4020 
                                                     DR-5 
CCCGCAGGCC TTACGGCAGT AGGGGAAACG CACTATTAAA GGGGAGAAAA TGGGAGATTA 4080 
   DR-5                                            DR-6                  DR-6* 
AAGGGGAGAT TTTGGGAATT ATTTAGGGGA GGTTTTGGGA GAATAAAGGA CGCTTTTGAG 4140 
                          DR-6                           A+T rich 2 
GAATAAAAAC GAGGTTTTGG GAGAATAAAG GGTAGAAAAT ATAAAAATCT CGTTTTTATG 4200 
            Rep A SC 
GTAGAATGCA GTCATGTCCG ATGAGATCGT GAAGTACTCG AACCAGTTCA ACAATCAGGC 4260 
               M  S   D  E  I  V   K  Y  S   N  Q  F   N  N  Q  A 
GCTGCGCAAG TTCACCGCGC TCGATCTTGA TTTGCTGATG GCCATCGCGT CTCGCGTGCG 4320 
  L  R  K   F  T  A   L  D  L  D   L  L  M   A  I  A   S  R  V  R  
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FIGURE LEGENDS 1 
 2 
Figure 1.- Physical and genetic map of pSP02. The colored arrows indicate the direction 3 
and approximate length of the identified ORFs. Direct repeats (DRs) and inverted repeats 4 
(IRs) are indicated over the plasmid boundary by red- and blue-filled vertical blocks 5 
respectively. DR-1/2 and DR-2/3 indicate overlapping pairs of direct repeats. The two AT-6 
rich regions are denoted by green-filled blocks. The position of the key restriction enzymes 7 
KpnI and BamHI sites is also indicated. 8 
 9 
Figure 2.- Detailed DNA sequence of the ori region of pSP02 and the initial part of its 10 
corresponding repA gene, plus the latter’s deduced amino acid sequence. Direct (DR) and 11 
inverted (IR) repeats are indicated by converging and same-direction arrows respectively; 12 
the numbering is as in Figure 2. The broken line indicates a copy of an imperfect DR6 13 
repeat. The two AT-rich sequences are boxed. 14 
 15 
Figure 3.- Diagram showing the construction of different pSP02-derived vectors. Ap
r
, Em
r
, 16 
and Tet
r
 indicate the ampicillin, erythromycin and tetracycline resistance genes 17 
respectively. 18 
 19 
Figure 4.- Hybridization detection of ssDNA during the replication of pSP02 in 20 
Bifidobacterium longum L25 using a digoxigenin labeled repA amplicon as a probe. Line 1, 21 
purified, untreated DNA from whole-cell extracts; Line 2, DNA treated with nuclease S1. 22 
M, molecular weight marker, digoxigenin-labeled lambda DNA digested with EcoRI. 23 
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